Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-16-550664
Filing Date
2016-04-22
Accepted
2016-04-21 19:54:09
Documents
5
Period of Report
2016-04-21

Document Format Files

Seq Description Document Type Size
1 6-K d183681d6k.htm 6-K 10574
2 EX-99.1 d183681dex991.htm EX-99.1 20067
3 GRAPHIC g183681img1.jpg GRAPHIC 27598
4 GRAPHIC g183681img2.jpg GRAPHIC 12593
5 GRAPHIC g183681img3.jpg GRAPHIC 10212
  Complete submission text file 0001193125-16-550664.txt   101415
Mailing Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 161585073
SIC: 2834 Pharmaceutical Preparations